Combined Peptide and Small-Molecule Approach toward Nonacidic THIQ Inhibitors of the KEAP1/NRF2 Interaction
Jesus M. Ontoria(IRBM Science Park), Steven J. Harper(Northwestern University), Esther Torrente(IRBM Science Park), Alexandros Patsilinakos(IRBM Science Park), Ilaria Biancofiore(IRBM Science Park), Federica Ferrigno(IRBM Science Park), Larry Park(CHDI Foundation), Ignacio Muñoz-Sanjuán(CHDI Foundation), Vincenzo Summa(IRBM Science Park), Stefan Steinbacher, Stefania Colarusso(IRBM Science Park), Leticia Toledo Sherman(CHDI Foundation), Celia Dominguez(CHDI Foundation), Elisabetta Bianchi(IRBM Science Park), Paola Fezzardi(IRBM Science Park), Alberto Bresciani(University of Bergamo), Matteo Andreini(Siena Biotech (Italy)), Martin Augustin, Georg Kempf, Robert E. Pacifici(CHDI Foundation)
Cited by 29
Related Papers
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope
|Proceedings of the National Academy of Sciences|2005|156
Design, Synthesis, and Biological Evaluation of Potent and Selective Class IIa Histone Deacetylase (HDAC) Inhibitors as a Potential Therapy for Huntington’s Disease
|Journal of Medicinal Chemistry|2013|149
Adipogenesis of skeletal muscle fibro/adipogenic progenitors is affected by the WNT5a/GSK3/β-catenin axis
|Cell Death and Differentiation|2020|149
Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor
|Circulation|2023|141
Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers
|Proceedings of the National Academy of Sciences|2011|139